Association of albumin-corrected serum calcium with all-cause mortality in older adults with mitral valve disease: a restricted cubic spline analysis of the China-DVD registry

Serum calcium has been associated with cardiovascular outcomes, but its relationship with mortality in mitral valve disease (MVD) is unclear. We examined the association between albumin-corrected serum calcium and all-cause mortality in older adults with moderate-to-severe MVD using restricted cubic spline (RCS) analysis. This prospective, multicentre cohort study used data from the China-DVD registry (ClinicalTrials.gov, NCT02865798). Patients aged ≥ 60 years with moderate-to-severe MVD were included; those with moderate-to-severe disease of other valves, previous valve surgery, infective endocarditis, missing or non-physiological laboratory values, or missing vital status were excluded. The primary outcome was all-cause mortality. Albumin-corrected calcium was calculated with the Payne formula. The primary adjusted model was prespecified to be parsimonious (corrected calcium, age, sex, coronary artery disease, pulmonary hypertension, left ventricular ejection fraction; 6 parameters, 19.0 events per parameter). Calcium was modelled as a 2-degree-of-freedom RCS with 3 knots at the 10th, 50th and 90th percentiles, and as quartiles. Twelve sensitivity analyses, including 1 retaining all observed values and a 30-day landmark analysis, were performed. Of 2,158 eligible patients, 1470 were analysed (mean age 69.5 ± 7.2 years; 47.7% men) and 114 deaths (7.8%) occurred during a median follow-up of 365 days (IQR 208–383). Mean albumin-corrected calcium was 9.00 ± 0.48 mg/dL. The spline showed a shallow non-monotonic association with the lowest risk at 8.9–9.0 mg/dL (overall association P = 0.107; nonlinearity P = 0.050). Risk was increased in the upper tail (9.8 mg/dL vs 9.0 mg/dL: HR 1.58, 95% CI 1.00–2.50; 10.2 mg/dL: HR 2.12, 95% CI 1.01–4.44), whereas lower tail estimates were compatible with the null. No quartile contrast was significant (highest vs lowest quartile: HR 1.35, 95% CI 0.84–2.16). Evidence of nonlinearity was present in only some sensitivity analyses and was attenuated after additional adjustment for albumin ( P = 0.042; quartile HR 1.20, 95% CI 0.75–1.93). Serum albumin was more strongly associated with mortality (HR 2.24 per 1 g/dL lower, 95% CI 1.45–3.46, P < 0.001), and serum phosphorus showed a borderline positive association (HR 1.21 per mg/dL, 95% CI 1.01–1.47, P = 0.043). In older adults with moderate-to-severe MVD, albumin-corrected serum calcium showed a shallow non-monotonic association with all-cause mortality, with the lowest risk near 8.9–9.0 mg/dL. The evidence for nonlinearity was borderline, no quartile contrast was significant, and the signal was attenuated after adjustment for albumin. These findings should therefore be regarded as hypothesis generating rather than as confirmation of an independent U-shaped association. Serum albumin was more strongly and consistently associated with mortality, and the calcium signal may partly reflect the prognostic information carried by albumin and by nutritional and inflammatory status. Trial registration ClinicalTrials.gov, NCT02865798; registered on 12 August 2016.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2026-11-17
DOI
https://doi.org/10.1186/s40001-026-05477-4
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of albumin-corrected serum calcium with all-cause mortality in older adults with mitral valve disease: a restricted cubic spline analysis of the China-DVD registry

Yongjian Wu, Ziang Li, Zhe Li, Bao-wen Lou et al.
1 links
European journal of medical research
Cardiac Valve Diseases and Treatments
article

Association of albumin-corrected serum calcium with all-cause mortality in older adults with mitral valve disease: a restricted cubic spline analysis of the China-DVD registry

Yongjian Wu, Ziang Li, Zhe Li, Bao-wen Lou, Qing-rong Liu, CHINA-DVD Collaborators, Hai-yan Xu, Hai-feng Su
article en

Abstract

Serum calcium has been associated with cardiovascular outcomes, but its relationship with mortality in mitral valve disease (MVD) is unclear. We examined the association between albumin-corrected serum calcium and all-cause mortality in older adults with moderate-to-severe MVD using restricted cubic spline (RCS) analysis. This prospective, multicentre cohort study used data from the China-DVD registry (ClinicalTrials.gov, NCT02865798). Patients aged ≥ 60 years with moderate-to-severe MVD were included; those with moderate-to-severe disease of other valves, previous valve surgery, infective endocarditis, missing or non-physiological laboratory values, or missing vital status were excluded. The primary outcome was all-cause mortality. Albumin-corrected calcium was calculated with the Payne formula. The primary adjusted model was prespecified to be parsimonious (corrected calcium, age, sex, coronary artery disease, pulmonary hypertension, left ventricular ejection fraction; 6 parameters, 19.0 events per parameter). Calcium was modelled as a 2-degree-of-freedom RCS with 3 knots at the 10th, 50th and 90th percentiles, and as quartiles. Twelve sensitivity analyses, including 1 retaining all observed values and a 30-day landmark analysis, were performed. Of 2,158 eligible patients, 1470 were analysed (mean age 69.5 ± 7.2 years; 47.7% men) and 114 deaths (7.8%) occurred during a median follow-up of 365 days (IQR 208–383). Mean albumin-corrected calcium was 9.00 ± 0.48 mg/dL. The spline showed a shallow non-monotonic association with the lowest risk at 8.9–9.0 mg/dL (overall association P = 0.107; nonlinearity P = 0.050). Risk was increased in the upper tail (9.8 mg/dL vs 9.0 mg/dL: HR 1.58, 95% CI 1.00–2.50; 10.2 mg/dL: HR 2.12, 95% CI 1.01–4.44), whereas lower tail estimates were compatible with the null. No quartile contrast was significant (highest vs lowest quartile: HR 1.35, 95% CI 0.84–2.16). Evidence of nonlinearity was present in only some sensitivity analyses and was attenuated after additional adjustment for albumin ( P = 0.042; quartile HR 1.20, 95% CI 0.75–1.93). Serum albumin was more strongly associated with mortality (HR 2.24 per 1 g/dL lower, 95% CI 1.45–3.46, P < 0.001), and serum phosphorus showed a borderline positive association (HR 1.21 per mg/dL, 95% CI 1.01–1.47, P = 0.043). In older adults with moderate-to-severe MVD, albumin-corrected serum calcium showed a shallow non-monotonic association with all-cause mortality, with the lowest risk near 8.9–9.0 mg/dL. The evidence for nonlinearity was borderline, no quartile contrast was significant, and the signal was attenuated after adjustment for albumin. These findings should therefore be regarded as hypothesis generating rather than as confirmation of an independent U-shaped association. Serum albumin was more strongly and consistently associated with mortality, and the calcium signal may partly reflect the prognostic information carried by albumin and by nutritional and inflammatory status. Trial registration ClinicalTrials.gov, NCT02865798; registered on 12 August 2016.

European journal of medical research
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Beijing Aerospace General Hospital (CN), Fu Wai Hospital (CN)
National Key Research and Development Program of China
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon